Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Fam107aem1/Cya
Common Name:
Fam107a-KO
Product ID:
S-KO-08586
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Fam107a-KO
Strain ID
KOCMP-268709-Fam107a-B6N-VA
Gene Name
Fam107a
Product ID
S-KO-08586
Gene Alias
DRR1
Background
C57BL/6NCya
NCBI ID
268709
Modification
Conventional knockout
Chromosome
14
Phenotype
MGI:3041256
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Fam107aem1/Cya mice (Catalog S-KO-08586) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000036070
NCBI RefSeq
NM_183187
Target Region
Exon 2~4
Size of Effective Region
~2.5 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Fam107a, Family with sequence similarity 107 member A, has emerged as a significant gene. It is thought to function as a tumor suppressor in various malignancies, affecting processes like tumor cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) [1,2,3,4,5,6,8,9]. In addition, it may be involved in regulating fat browning in adipocytes, adipogenesis, and lipid metabolism [7].

Multiple studies across different cancer types have shown its reduced expression in tumors. For instance, in esophageal squamous carcinoma, its low expression was linked to a poorer prognosis, and overexpression inhibited cell proliferation, invasion, and the EMT process [1]. In bladder cancer, its down-regulation was associated with high tumor grade, and restoring its expression suppressed cell growth, migration, and invasion [2]. In prostate cancer, hypermethylation of CpG islands led to Fam107a down-regulation, and overexpression inhibited tumor cell behaviors through the FAK/PI3K/AKT signaling pathway [3]. Pan-cancer analysis indicated its down-regulated expression was related to poor survival, and in vitro experiments showed that knockdown promoted the proliferation, migration, and invasion of bladder and renal cancer cells [4].

In conclusion, Fam107a is mainly recognized as a tumor suppressor, influencing tumor-related biological processes in various cancers. The findings from these functional studies, including those from in vitro cell-based experiments, provide insights into its role in disease. Understanding Fam107a's functions may offer potential diagnostic and therapeutic targets for cancers and other related metabolic disorders [1,2,3,4,5,6,7,8,9].

References:

1. Zhang, Jiale, Di, Shouyin, Li, Mingyang, Jia, Qingge, Fan, Boshi. 2023. FAM107A as a tumor suppressor in esophageal squamous carcinoma inhibits growth and metastasis. In Pathology, research and practice, 252, 154945. doi:10.1016/j.prp.2023.154945. https://pubmed.ncbi.nlm.nih.gov/37977035/

2. Ou, Longhua, Wei, Zhengmao, Xu, Jinming, Wang, Yan, Shi, Bentao. . FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and Invasion. In Annals of clinical and laboratory science, 52, 260-268. doi:. https://pubmed.ncbi.nlm.nih.gov/35414505/

3. Ke, Shuai, Liu, Zelin, Wang, Qinghua, Yu, Xi, Guo, Jia. 2022. FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway. In Cancers, 14, . doi:10.3390/cancers14163915. https://pubmed.ncbi.nlm.nih.gov/36010909/

4. Ou, Dehua, Zhang, Zhiqin, Wu, Zesong, She, Sifan, Lin, Ming-En. 2022. Identification of the Putative Tumor Suppressor Characteristics of FAM107A via Pan-Cancer Analysis. In Frontiers in oncology, 12, 861281. doi:10.3389/fonc.2022.861281. https://pubmed.ncbi.nlm.nih.gov/35669436/

5. Ma, Yun-Fei, Li, Guang-Da, Sun, Xu, Yu, Ming-Wei, Wang, Xiao-Min. 2021. Identification of FAM107A as a potential biomarker and therapeutic target for prostate carcinoma. In American journal of translational research, 13, 10163-10177. doi:. https://pubmed.ncbi.nlm.nih.gov/34650688/

6. Ming, Fei, Zhang, DaiPing. 2025. FAM107A Inhibits the Growth, Invasion and Aerobic Glycolysis of LUAD Cells by Regulating CRYAB/PI3K/AKT. In Biochemical genetics, , . doi:10.1007/s10528-024-11006-x. https://pubmed.ncbi.nlm.nih.gov/39751722/

7. Manigandan, Subramani, Mukherjee, Sulagna, Yun, Jong Won. 2021. Loss of family with sequence similarity 107, member A (FAM107A) induces browning in 3T3-L1 adipocytes. In Archives of biochemistry and biophysics, 704, 108885. doi:10.1016/j.abb.2021.108885. https://pubmed.ncbi.nlm.nih.gov/33878327/

8. Pastuszak-Lewandoska, D, Czarnecka, K H, Migdalska-Sęk, M, Górski, P, Brzeziańska-Lasota, E. . Decreased FAM107A Expression in Patients with Non-small Cell Lung Cancer. In Advances in experimental medicine and biology, 852, 39-48. doi:10.1007/5584_2014_109. https://pubmed.ncbi.nlm.nih.gov/25753555/

9. Kiwerska, Katarzyna, Szaumkessel, Marcin, Paczkowska, Julia, Marszałek, Andrzej, Giefing, Maciej. 2017. Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumors. In Scientific reports, 7, 5386. doi:10.1038/s41598-017-05857-1. https://pubmed.ncbi.nlm.nih.gov/28710449/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest